Ekkehard Lang

Dr. Ekkehard Lang

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in British Journal of Plastic Surgery
Verified
Journal Article
Closed access
MKMichael Kremer
Michael Kremer
ELEkkehard Lang
Ekkehard Lang
ABAlfred Berger
Alfred Berger


1 November 1996 in Experimental Cell Research
Verified
Journal Article
Closed access
BSBirgit M. Schaefer
Birgit M. Schaefer
JRJeannette Reinartz
Jeannette Reinartz
MBMichael J. Bechtel
Michael J. Bechtel
SIStefan Inndorf
Stefan Inndorf
ELEkkehard Lang
Ekkehard Lang
MKMichael D. Kramer
Michael D. Kramer

29 July 2025 in Cells
Verified
Journal Article
Open access
PDF file
JMJohannes De Munter
Johannes De Munter
KCKirill D. Chaprov
Kirill D. Chaprov
ELEkkehard Lang
Ekkehard Lang
KSKseniia Sitdikova
Kseniia Sitdikova
EWErik Charles Wolters
Erik Charles Wolters
TSTatyana Strekalova
Tatyana Strekalova
Neuroinflammation is a key feature of Alzheimer’s disease (AD), and stem cell therapies have emerged as promising candidates due to their immunomodulatory properties. Neuro-Cells (NC), a combination of unmodified mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs), have demonstrated therapeutic potential in models of central nervous system (CNS) injury and neurodegeneration. Here, we studied the effects of NC in APPswe/PS1dE9 mice, an AD mouse model. Twelve-month-old APPswe/PS1dE9 mice or their wild-type littermates were injected with NC or vehicle into the cisterna magna. Five to six weeks post-injection, cognitive, locomotor, and emotional behaviors were assessed. The brain was stained for amyloid plaque density using Congo red, and for astrogliosis using DAPI and GFAP staining. Gene expression of immune activation markers (Il-1β, Il-6, Cd45, Tnf) and plasticity markers (Tubβ3, Bace1, Trem2, Stat3) was examined in the prefrontal cortex. IL-6 secretion was measured in cultured human monocytes following endotoxin challenge and NC treatment. Untreated APPswe/PS1dE9 mice displayed impaired learning in the conditioned taste aversion test, reduced object exploration, and anxiety-like behavior, which were improved in the NC-treated mutants. NC treatment normalized the expression of several immune and plasticity markers and reduced the density of GFAP-positive cells in the hippocampus and thalamus. NC treatment decreased amyloid plaque density in the hippocampus and thalamus, targeting plaques of <100 μm2. Additionally, NC treatment suppressed IL-6 secretion by human monocytes. Thus, NC treatment alleviated behavioral deficits and reduced amyloid plaque formation in APPswe/PS1dE9 mice, likely via anti-inflammatory mechanisms. The reduction in IL-6 production in human monocytes further supports the potential of NC therapy for the treatment of AD.

1 September 1996 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ELEkkehard Lang
Ekkehard Lang
BSBirgit M. Schaefer
Birgit M. Schaefer
UEUlrich Eickhoff
Ulrich Eickhoff
HHHans-Peter Hohl
Hans-Peter Hohl
MKMichael D. Kramer
Michael D. Kramer
KMKatharina Maier-Reif
Katharina Maier-Reif